August 9, 2025

Development and Evaluation of a Multi-Epitope Vaccine Based on P22 Virus-Like Particles Targeting Helicobacter pylori.

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Development of a vaccine reduces Helicobacter pylori infection rates in mice, suggesting a new approach against antibiotic resistance.

P22-C3 is a multi-epitope vaccine developed to combat Helicobacter pylori infections.
In vivo experiments showed that P22-C3 induced a strong IgG response and mixed Th1/Th17 immune profile.
The safety and efficacy of P22-C3 were confirmed through various in vitro and in vivo assessments.
Immunized mice displayed lower bacterial loads and urease levels, indicating effective protection against H. pylori.

Zhu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark